Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HPF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
USH1C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928259 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MAPK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMCHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADCK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SASH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAX1BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAND1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEL1L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BICD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL18BP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYDGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP64 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALMS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3C2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on